NCT03130790 2022-02-15
Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line)
ASLAN Pharmaceuticals
Phase 2/3 Completed
Clinical Trials
4 trialsNCT03093870 2021-08-03
TreeTopp
ASLAN Pharmaceuticals
Phase 2/3 Completed
NCT02609958 2018-05-29
ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy
ASLAN Pharmaceuticals
Phase 2 Completed
NCT00862524 2012-10-04
A Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic Cancer
Array BioPharma
Phase 1/2 Completed